-
1
-
-
0026464493
-
Boron neutron capture therapy for cancer: Realities and prospects
-
Barth RF, Soloway AH and Fairchild RG: Boron neutron capture therapy for cancer: realities and prospects. Cancer 70: 2995-3007, 1992.
-
(1992)
Cancer
, vol.70
, pp. 2995-3007
-
-
Barth, R.F.1
Soloway, A.H.2
Fairchild, R.G.3
-
2
-
-
33745945620
-
The role of chemistry in the development of boron neutron capture therapy of cancer
-
Hawthorne MF: The role of chemistry in the development of boron neutron capture therapy of cancer. Angew Chem Int Ed Engl 32: 950-984, 1993.
-
(1993)
Angew Chem Int Ed Engl
, vol.32
, pp. 950-984
-
-
Hawthorne, M.F.1
-
4
-
-
0041725883
-
-
Madison, WI, Advanced Medical Publishing
-
Zamenhof R, Solares G, Harling O (eds): Topics in Dosimetry & Treatment Planning for Neutron Capture Therapy. Madison, WI, Advanced Medical Publishing, 1994.
-
(1994)
Topics in Dosimetry & Treatment Planning for Neutron Capture Therapy
-
-
Zamenhof, R.1
Solares, G.2
Harling, O.3
-
5
-
-
0027950222
-
Boronated starburst dendrimer-monoclonal antibody immunoconjugates: Evaluation as a potential delivery system for neutron capture therapy
-
Barth RF, Adams DM, Solovay AH, Alam F and Darby MV: Boronated starburst dendrimer-monoclonal antibody immunoconjugates: Evaluation as a potential delivery system for neutron capture therapy. Bioconjugate Chem 5: 58-66, 1994.
-
(1994)
Bioconjugate Chem
, vol.5
, pp. 58-66
-
-
Barth, R.F.1
Adams, D.M.2
Solovay, A.H.3
Alam, F.4
Darby, M.V.5
-
7
-
-
0001303221
-
Recombination of a mixture of univalent antibody fragments of different specificity
-
Nisonoff A and Rivers MM: Recombination of a mixture of univalent antibody fragments of different specificity. Arch Biochem Biophys 93: 460-462, 1961.
-
(1961)
Arch Biochem Biophys
, vol.93
, pp. 460-462
-
-
Nisonoff, A.1
Rivers, M.M.2
-
8
-
-
0021751543
-
Production of target specific effector cells using hetero-cross-linked aggregates containing anti-target cell and anti-Fcγ receptor antibodies
-
Karpovsky B, Titus JA, Stephany DA and Segal DM: Production of target specific effector cells using hetero-cross-linked aggregates containing anti-target cell and anti-Fcγ receptor antibodies. J Exp Med 160: 1686-1701, 1984.
-
(1984)
J Exp Med
, vol.160
, pp. 1686-1701
-
-
Karpovsky, B.1
Titus, J.A.2
Stephany, D.A.3
Segal, D.M.4
-
10
-
-
0347837431
-
Procedures for in vitro immunization and monoclonal antibody production
-
BH Tom and JP Allison (eds), NewYork, Plenum Press
-
Reading CL: Procedures for in vitro immunization and monoclonal antibody production. In: BH Tom and JP Allison (eds), Hybridomas and Cellular Immortality pp 235-250. NewYork, Plenum Press, 1983.
-
(1983)
Hybridomas and Cellular Immortality
, pp. 235-250
-
-
Reading, C.L.1
-
12
-
-
0023144221
-
Bispecific antibody-producing hybrid hybridomas selected by a fluorescence activated cell sorter
-
Karawajew L, Micheel B, Behrsing O and Gaestel M: Bispecific antibody-producing hybrid hybridomas selected by a fluorescence activated cell sorter J Immunol Methods 96: 265-270, 1987.
-
(1987)
J Immunol Methods
, vol.96
, pp. 265-270
-
-
Karawajew, L.1
Micheel, B.2
Behrsing, O.3
Gaestel, M.4
-
13
-
-
0023865669
-
IgA:IgM and IgA:IgA hybrid hybridomas secrete heteropolymeric immunoglobulins that are polyvalent and bispecific
-
Urnovitz HB, Chang Y, Scott M, Fleischman J and Lynch RG: IgA:IgM and IgA:IgA hybrid hybridomas secrete heteropolymeric immunoglobulins that are polyvalent and bispecific. J Immunol 140: 558-563, 1988.
-
(1988)
J Immunol
, vol.140
, pp. 558-563
-
-
Urnovitz, H.B.1
Chang, Y.2
Scott, M.3
Fleischman, J.4
Lynch, R.G.5
-
14
-
-
0020518331
-
Hybrid hybridomas and their use in immunohistochemistry
-
Milstein C and Cuello AC: Hybrid hybridomas and their use in immunohistochemistry. Nature 305: 537-540, 1983.
-
(1983)
Nature
, vol.305
, pp. 537-540
-
-
Milstein, C.1
Cuello, A.C.2
-
15
-
-
0021840231
-
Evidence for a novel hybrid immunotoxin recognizing ricin A-chain by on antigen-combining site and a prostate-restricted antigen by the remaining antigen-combining site: Potential for immunotherapy
-
Webb KS, Ware JL, Parks SF, Walther PJ and Paulson DF: Evidence for a novel hybrid immunotoxin recognizing ricin A-chain by on antigen-combining site and a prostate-restricted antigen by the remaining antigen-combining site: potential for immunotherapy. Cancer Treatment Rep 69: 663-672, 1985.
-
(1985)
Cancer Treatment Rep
, vol.69
, pp. 663-672
-
-
Webb, K.S.1
Ware, J.L.2
Parks, S.F.3
Walther, P.J.4
Paulson, D.F.5
-
16
-
-
0021716682
-
Chimeric human antibody molecules: Mouse antigen-binding domains with human constant region domains
-
Morrison SL, Johnson MJ, Herzenberg LA and Oi VT: Chimeric human antibody molecules: Mouse antigen-binding domains with human constant region domains. Proc Natl Acad Sci U.S.A. 81: 6851-6855, 1984.
-
(1984)
Proc Natl Acad Sci U.S.A.
, vol.81
, pp. 6851-6855
-
-
Morrison, S.L.1
Johnson, M.J.2
Herzenberg, L.A.3
Oi, V.T.4
-
17
-
-
0021713342
-
Production of functional chimeric mouse/human antibody
-
Boulianne GL, Houzumi N and Shulman MJ: Production of functional chimeric mouse/human antibody. Nature 312: 643-646, 1984.
-
(1984)
Nature
, vol.312
, pp. 643-646
-
-
Boulianne, G.L.1
Houzumi, N.2
Shulman, M.J.3
-
18
-
-
0021826932
-
A hapten-specific chimeric IgE antibody with human physiological effector function
-
Neuberger MS, Williams GT, Mitchell EB, Jouhal SS, Flanagan JG and Rabbitts TH: A hapten-specific chimeric IgE antibody with human physiological effector function. Nature 314: 268-270, 1985.
-
(1985)
Nature
, vol.314
, pp. 268-270
-
-
Neuberger, M.S.1
Williams, G.T.2
Mitchell, E.B.3
Jouhal, S.S.4
Flanagan, J.G.5
Rabbitts, T.H.6
-
19
-
-
0022558297
-
Replacing the complementarity-determining regions in a human antibody with those from a mouse
-
Jones PT, Dear PH, Foote J, Neuberger MS and Winter G: Replacing the complementarity-determining regions in a human antibody with those from a mouse. Nature 321: 522-525 1986.
-
(1986)
Nature
, vol.321
, pp. 522-525
-
-
Jones, P.T.1
Dear, P.H.2
Foote, J.3
Neuberger, M.S.4
Winter, G.5
-
20
-
-
0004198722
-
Protein engineering of antibody binding sites: Recovery of specific activity in an antidigoxin single chain Fv analogue produced in Escherichia coli
-
Huston JS, Levinson D, Mudgett-Hunter M, Tai M-S, Novotny J, Margolies MN, Ridge RJ, Bruccoleri RE, Haber E, Crea R and Oppermann H: Protein engineering of antibody binding sites: recovery of specific activity in an antidigoxin single chain Fv analogue produced in Escherichia coli. Proc Natl Acad Sci U.S.A. 85: 5879-5883, 1988.
-
(1988)
Proc Natl Acad Sci U.S.A.
, vol.85
, pp. 5879-5883
-
-
Huston, J.S.1
Levinson, D.2
Mudgett-Hunter, M.3
Tai, M.-S.4
Novotny, J.5
Margolies, M.N.6
Ridge, R.J.7
Bruccoleri, R.E.8
Haber, E.9
Crea, R.10
Oppermann, H.11
-
21
-
-
0024293979
-
Single-chain antigen-binding proteins
-
Bird RE, Hardman D, Jacobson JW, Johnson S, Kaufman BE, Lee SM, Pope SH, Riordan GS and Whitlow M: Single-chain antigen-binding proteins. Science 242: 423-426, 1988.
-
(1988)
Science
, vol.242
, pp. 423-426
-
-
Bird, R.E.1
Hardman, D.2
Jacobson, J.W.3
Johnson, S.4
Kaufman, B.E.5
Lee, S.M.6
Pope, S.H.7
Riordan, G.S.8
Whitlow, M.9
-
22
-
-
0024434669
-
A novel strategy for producing chimeric bispecific antibodies by gene transfection
-
Songsivilai S, Clissold PM and Lachmann PJ: A novel strategy for producing chimeric bispecific antibodies by gene transfection. Biochem Res Commun 64: 271-276, 1989.
-
(1989)
Biochem Res Commun
, vol.64
, pp. 271-276
-
-
Songsivilai, S.1
Clissold, P.M.2
Lachmann, P.J.3
-
23
-
-
0028989969
-
Tumor therapy by immune recruitment with bispecific antibodies
-
Renner C and Pfreundshuh M: Tumor therapy by immune recruitment with bispecific antibodies. Immunol Reviews 145: 179-209, 1995.
-
(1995)
Immunol Reviews
, vol.145
, pp. 179-209
-
-
Renner, C.1
Pfreundshuh, M.2
-
24
-
-
0021832361
-
Hybrid antibodies can target sites for attack by T cells
-
Staerz UD, Kanagawa O and Bevan MJ: Hybrid antibodies can target sites for attack by T cells. Nature 314: 628-631, 1985.
-
(1985)
Nature
, vol.314
, pp. 628-631
-
-
Staerz, U.D.1
Kanagawa, O.2
Bevan, M.J.3
-
25
-
-
0023619381
-
Lysis of tumor cells by the retargeting of murine cytolytic T lymphocyte; with bispecific antibodies
-
Barr IG, McDonald HR, Buchegger F and Von Fliedner V: Lysis of tumor cells by the retargeting of murine cytolytic T lymphocyte; with bispecific antibodies. Int J Cancer 40: 423-429, 1987.
-
(1987)
Int J Cancer
, vol.40
, pp. 423-429
-
-
Barr, I.G.1
McDonald, H.R.2
Buchegger, F.3
Von Fliedner, V.4
-
26
-
-
0023740192
-
Cytolysis by cloned helper T cells: Induction by specific antigen or by anti-CD3 hybrid antibodies
-
Vyakamam A, Strangeways AL, Glover RE and Lachmann PJ: Cytolysis by cloned helper T cells: induction by specific antigen or by anti-CD3 hybrid antibodies. Scand J Immunol 27: 635-644, 1988.
-
(1988)
Scand J Immunol
, vol.27
, pp. 635-644
-
-
Vyakamam, A.1
Strangeways, A.L.2
Glover, R.E.3
Lachmann, P.J.4
-
27
-
-
0025095459
-
Induction of cytotoxicity in human T cells coated with anti-glioma X anti-CD3 bispecific antibody against human glioma cells
-
Nitta T, Sato K, Okumura K and Ishii S: Induction of cytotoxicity in human T cells coated with anti-glioma X anti-CD3 bispecific antibody against human glioma cells. J Neurosurg 72: 476-481, 1990.
-
(1990)
J Neurosurg
, vol.72
, pp. 476-481
-
-
Nitta, T.1
Sato, K.2
Okumura, K.3
Ishii, S.4
-
28
-
-
0023092226
-
Specific in vitro and in vivo drug localization of tumor cells using a hybrid-hybrid monoclonal antibody recognizing both carcinoembryonic antigen (CEA) and vincal alkloids
-
Corvalan JRF, Smith W, Gore VA and Brandon DR: Specific in vitro and in vivo drug localization of tumor cells using a hybrid-hybrid monoclonal antibody recognizing both carcinoembryonic antigen (CEA) and vincal alkloids. Cancer Immunol Immunother 24: 133-137 1987.
-
Cancer Immunol Immunother
, vol.24
, pp. 133-1371987
-
-
Corvalan, J.R.F.1
Smith, W.2
Gore, V.A.3
Brandon, D.R.4
-
29
-
-
0024660466
-
The effect of bispecific monoclonal antibody recognizing both hepatoma specific membrane glycoprotein and anthracyclin drugs on the metastatic growth of hepatoma AH66
-
Tsukada Y, Ohkawa K, Hibi N, Tsuzuki K, Oguma K and Satoh H: The effect of bispecific monoclonal antibody recognizing both hepatoma specific membrane glycoprotein and anthracyclin drugs on the metastatic growth of hepatoma AH66. Cancer Biochem Biophys 10: 247-256, 1989.
-
(1989)
Cancer Biochem Biophys
, vol.10
, pp. 247-256
-
-
Tsukada, Y.1
Ohkawa, K.2
Hibi, N.3
Tsuzuki, K.4
Oguma, K.5
Satoh, H.6
-
30
-
-
0027216217
-
Targeting of saporin to CD25-positive normal and neoplastic lymphocytes by an anti-saporin/anti-CD25 bispecific monoclonal antibody: In vitro evaluation
-
Tazzaru PL, Zhang S, Chen Q, Sforzini S, Bolognesi A, Stirpe F, Xie H, Moretta A and Ferrini S: Targeting of saporin to CD25-positive normal and neoplastic lymphocytes by an anti-saporin/anti-CD25 bispecific monoclonal antibody: in vitro evaluation. Br J Cancer 67: 1248-1253, 1993.
-
(1993)
Br J Cancer
, vol.67
, pp. 1248-1253
-
-
Tazzaru, P.L.1
Zhang, S.2
Chen, Q.3
Sforzini, S.4
Bolognesi, A.5
Stirpe, F.6
Xie, H.7
Moretta, A.8
Ferrini, S.9
-
31
-
-
10544227097
-
Production of monoclonal antibodies (MoAbs) reactive with boronated isocyanate for BNCT
-
Liu L, Adams DM, Barth RF and Soloway AH: Production of monoclonal antibodies (MoAbs) reactive with boronated isocyanate for BNCT. Proc Am Assoc Cancer Res 34: 474, 1993.
-
(1993)
Proc Am Assoc Cancer Res
, vol.34
, pp. 474
-
-
Liu, L.1
Adams, D.M.2
Barth, R.F.3
Soloway, A.H.4
-
32
-
-
0028862811
-
Bispecific antibodies as targeting agents for boron neutron capture therapy of brain tumors
-
Liu L, Barth RF, Adams DM, Soloway AH and Reisfeld RA: Bispecific antibodies as targeting agents for boron neutron capture therapy of brain tumors. J Hematotherapy 4: 477-483 1995.
-
(1995)
J Hematotherapy
, vol.4
, pp. 477-483
-
-
Liu, L.1
Barth, R.F.2
Adams, D.M.3
Soloway, A.H.4
Reisfeld, R.A.5
-
33
-
-
0026425579
-
Correlation of chondroitin sulfate proteoglycan expression on proliferating brain capillary endothelial cells with the malignant phenotype of astroglial cells
-
Schrappe M Klier GF Spiro RC Walts TA and Reisfeld RA: Correlation of chondroitin sulfate proteoglycan expression on proliferating brain capillary endothelial cells with the malignant phenotype of astroglial cells. Cancer Res 51: 4986-4993, 1991.
-
(1991)
Cancer Res
, vol.51
, pp. 4986-4993
-
-
Schrappe, M.1
Klier, G.F.2
Spiro, R.C.3
Walts, T.A.4
Reisfeld, R.A.5
-
34
-
-
0022508883
-
Hybrid hybridoma producing a bispecific monoclonal antibody that can focus effector T-cell activity
-
Staez UD and Bevan MJ: Hybrid hybridoma producing a bispecific monoclonal antibody that can focus effector T-cell activity. Proc Natl Acad Sci U.S.A. 83: 1453-1457, 1986.
-
(1986)
Proc Natl Acad Sci U.S.A.
, vol.83
, pp. 1453-1457
-
-
Staez, U.D.1
Bevan, M.J.2
-
35
-
-
0027413271
-
Purification of monoclonal antibodies from tissue culture medium depleted of IgG
-
Darby CR, Hamano K and Wood KJ: Purification of monoclonal antibodies from tissue culture medium depleted of IgG. J Immunol Methods 159: 125-129, 1993.
-
(1993)
J Immunol Methods
, vol.159
, pp. 125-129
-
-
Darby, C.R.1
Hamano, K.2
Wood, K.J.3
-
36
-
-
0017106288
-
Isolation and characterization of low and high affinity goat antibodies directed to single antigenic sites on human hemoglobin
-
Tan-Wilson AL, Reichlin M and Noble RW: Isolation and characterization of low and high affinity goat antibodies directed to single antigenic sites on human hemoglobin. Immunochemistry 13: 921-927, 1977.
-
(1977)
Immunochemistry
, vol.13
, pp. 921-927
-
-
Tan-Wilson, A.L.1
Reichlin, M.2
Noble, R.W.3
-
37
-
-
0017351507
-
Purification and iodination of antibody for use in an immunoradiometric assay for serum ferritin
-
Gonyea LM: Purification and iodination of antibody for use in an immunoradiometric assay for serum ferritin. Clin Chem 23: 234-236 1977.
-
Clin Chem
, vol.23
, pp. 234-2361977
-
-
Gonyea, L.M.1
-
38
-
-
0014949207
-
Cleavage of structural proteins during assembly of the head of bacteriophage T4
-
Laemli UK: Cleavage of structural proteins during assembly of the head of bacteriophage T4. Nature 227: 680-685, 1970.
-
(1970)
Nature
, vol.227
, pp. 680-685
-
-
Laemli, U.K.1
-
39
-
-
0020971339
-
Enzyme-linked immunosorbent assay for screening monoclonal antibody production using enzyme-labeled second antibody
-
Douillard JY and Huffman T: Enzyme-linked immunosorbent assay for screening monoclonal antibody production using enzyme-labeled second antibody. Methods in Fnzymology 92: 168-174, 1983.
-
(1983)
Methods in Fnzymology
, vol.92
, pp. 168-174
-
-
Douillard, J.Y.1
Huffman, T.2
-
41
-
-
84969001783
-
The attractions of proteins for small molecules and ions
-
Scatchard G: The attractions of proteins for small molecules and ions. Ann N.Y. Acad Sci 51: 660-672, 1949.
-
(1949)
Ann N.Y. Acad Sci
, vol.51
, pp. 660-672
-
-
Scatchard, G.1
-
42
-
-
0019780712
-
Growth and chemotherapeutic responses in athymic mice of tumors arising from human glioma-derived cell lines
-
Bullard DE, Schold SC, Bigner SH and Bigner DD: Growth and chemotherapeutic responses in athymic mice of tumors arising from human glioma-derived cell lines. J Neuropathol Exp Neurol 40: 410-427, 1981.
-
(1981)
J Neuropathol Exp Neurol
, vol.40
, pp. 410-427
-
-
Bullard, D.E.1
Schold, S.C.2
Bigner, S.H.3
Bigner, D.D.4
-
43
-
-
0020546834
-
Growth, morphology and serial transplantation of anaplastic human gliomas in athymic mice
-
Schold SC Jr, Bullard DE, Bigner SH, Jones TR and Bigner DD: Growth, morphology and serial transplantation of anaplastic human gliomas in athymic mice. J Neuro-Oncol 1: 5-14 1983.
-
(1983)
J Neuro-Oncol
, vol.1
, pp. 5-14
-
-
Schold Jr., S.C.1
Bullard, D.E.2
Bigner, S.H.3
Jones, T.R.4
Bigner, D.D.5
-
44
-
-
0022585652
-
In vitro imaging of intracranial human glioma xenografts comparing specific with nonspecific radiolabeled monoclonal antibodies
-
Bullard DE, Adams CJ, Coleman RE and Bigner DD: In vitro imaging of intracranial human glioma xenografts comparing specific with nonspecific radiolabeled monoclonal antibodies. J Neurosurg 6: 257-262, 1986.
-
(1986)
J Neurosurg
, vol.6
, pp. 257-262
-
-
Bullard, D.E.1
Adams, C.J.2
Coleman, R.E.3
Bigner, D.D.4
-
45
-
-
0023121149
-
Comparative localization of glioma-reactive monoclonal antibodies in vivo in an athymic mouse human glioma xenograft model
-
Wikstrand CJ, McLendon RE, Carrel S, Kemshead JT, Mach J-P, Coakham HB, Tribolet Nde, Bullard DE, Zalutsky MR and Bigner DD: Comparative localization of glioma-reactive monoclonal antibodies in vivo in an athymic mouse human glioma xenograft model. J Neuroimmunol 15: 37-56 1987.
-
(1987)
J Neuroimmunol
, vol.15
, pp. 37-56
-
-
Wikstrand, C.J.1
McLendon, R.E.2
Carrel, S.3
Kemshead, J.T.4
Mach, J.-P.5
Coakham, H.B.6
Tribolet, Nde.7
Bullard, D.E.8
Zalutsky, M.R.9
Bigner, D.D.10
-
47
-
-
0015759232
-
In vitro cultivation of human tumors: Establishment of cell lines derived from a series of solid tumors
-
Giard DJ, Aaronson SA, Todaro GJ, Arnstein P, Kersey JH, Dosile H and Parks WP: In vitro cultivation of human tumors: establishment of cell lines derived from a series of solid tumors. J Natl Cancer Inst 51: 1417-1423, 1973.
-
(1973)
J Natl Cancer Inst
, vol.51
, pp. 1417-1423
-
-
Giard, D.J.1
Aaronson, S.A.2
Todaro, G.J.3
Arnstein, P.4
Kersey, J.H.5
Dosile, H.6
Parks, W.P.7
-
48
-
-
0001416087
-
The possible use of neutron-capture isotopes such as boron-10 in the treatment of neoplasms: II. computation of the radiation energy and estimates of effects in normal and neoplastic brain
-
Javid M, Brownell GL and Sweet WH: The possible use of neutron-capture isotopes such as boron-10 in the treatment of neoplasms: II. computation of the radiation energy and estimates of effects in normal and neoplastic brain. J Clin Invest 31: 603-610, 1952.
-
(1952)
J Clin Invest
, vol.31
, pp. 603-610
-
-
Javid, M.1
Brownell, G.L.2
Sweet, W.H.3
-
50
-
-
0029921556
-
Enhanced delivery of boronophenylalanine for neutron capture therapy by means of intracarotid injection and blood brain barrier disruption
-
Yang WL, Barth RF, Carpenter DE, Moeschberger ML and Goodman JH: Enhanced delivery of boronophenylalanine for neutron capture therapy by means of intracarotid injection and blood brain barrier disruption. Neurosurg 38: 985-992, 1996.
-
(1996)
Neurosurg
, vol.38
, pp. 985-992
-
-
Yang, W.L.1
Barth, R.F.2
Carpenter, D.E.3
Moeschberger, M.L.4
Goodman, J.H.5
-
51
-
-
0028297726
-
Clinical results of long-surviving brain tumor patients who underwent boron capture therapy
-
Hatanaka H and Nakagawa Y: Clinical results of long-surviving brain tumor patients who underwent boron capture therapy. Int J Radiation Oncology Biol Phys 28: 1061-1066, 1994.
-
(1994)
Int J Radiation Oncology Biol Phys
, vol.28
, pp. 1061-1066
-
-
Hatanaka, H.1
Nakagawa, Y.2
-
52
-
-
10544247596
-
Boron neutron capture therapy for glioblastoma multiforme using p-boronophenylalanine and epithermal neutrons: Trial design and early clinical results
-
In Press
-
Coderre JA, Elositz EH, Chadha M, Bergland R, Capala J, Joel DD, Liu HB, Slatkin DN and Chanana AD: Boron neutron capture therapy for glioblastoma multiforme using p-boronophenylalanine and epithermal neutrons: trial design and early clinical results. J Neuro-oncology. (In Press) 1996.
-
(1996)
J Neuro-oncology
-
-
Coderre, J.A.1
Elositz, E.H.2
Chadha, M.3
Bergland, R.4
Capala, J.5
Joel, D.D.6
Liu, H.B.7
Slatkin, D.N.8
Chanana, A.D.9
-
53
-
-
0029051665
-
Bispecific monoclonal antibody ant-CD3 × anti-terrascin: An immunotherapeutic agent for human glioma
-
Bonino LD, De Monte BD, Spagnoli GC, Vola R, Mariani M, Barone D, Moro AM, Riva P, Nicotra MR, Natali PG and Malavasi F: Bispecific monoclonal antibody ant-CD3 × anti-terrascin: an immunotherapeutic agent for human glioma. Int J Cancer 61: 509-515, 1995.
-
(1995)
Int J Cancer
, vol.61
, pp. 509-515
-
-
Bonino, L.D.1
De Monte, B.D.2
Spagnoli, G.C.3
Vola, R.4
Mariani, M.5
Barone, D.6
Moro, A.M.7
Riva, P.8
Nicotra, M.R.9
Natali, P.G.10
Malavasi, F.11
|